Highland Capital Management, LLC Eli Lilly & CO Transaction History

Highland Capital Management, LLC

  • $1.73 Billion
  • Q3 2024

A detailed history of Highland Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Highland Capital Management, LLC holds 12,198 shares of LLY stock, worth $9.71 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
12,198
Previous 12,498 2.4%
Holding current value
$9.71 Million
Previous $11.3 Million 4.5%
% of portfolio
0.62%
Previous 0.67%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$772.14 - $960.02 $231,642 - $288,006
-300 Reduced 2.4%
12,198 $10.8 Million
Q2 2024

Jul 25, 2024
SELL
$724.87 - $909.04 $638,610 - $800,864
-881 Reduced 6.58%
12,498 $11.3 Million
Q1 2024

May 07, 2024
BUY
$592.2 - $792.28 $17,173 - $22,976
29 Added 0.22%
13,379 $10.4 Million
Q4 2023

Jan 17, 2024
BUY
$525.19 - $619.13 $189,068 - $222,886
360 Added 2.77%
13,350 $7.78 Million
Q3 2023

Nov 14, 2023
BUY
$434.7 - $599.3 $19,996 - $27,567
46 Added 0.36%
12,990 $6.98 Million
Q2 2023

Aug 09, 2023
SELL
$350.74 - $468.98 $300,233 - $401,446
-856 Reduced 6.2%
12,944 $6.07 Million
Q1 2023

May 11, 2023
BUY
$310.63 - $364.82 $127,979 - $150,305
412 Added 3.08%
13,800 $4.74 Million
Q4 2022

Feb 07, 2023
BUY
$321.55 - $374.67 $789,405 - $919,814
2,455 Added 22.45%
13,388 $4.9 Million
Q3 2022

Nov 09, 2022
BUY
$296.48 - $337.87 $18,974 - $21,623
64 Added 0.59%
10,933 $3.54 Million
Q2 2022

Jul 14, 2022
SELL
$278.73 - $327.27 $55,746 - $65,454
-200 Reduced 1.81%
10,869 $3.52 Million
Q1 2022

Apr 19, 2022
BUY
$234.69 - $291.66 $61,723 - $76,706
263 Added 2.43%
11,069 $3.17 Million
Q4 2021

Jan 28, 2022
BUY
$224.85 - $279.04 $207,311 - $257,274
922 Added 9.33%
10,806 $2.99 Million
Q3 2021

Oct 25, 2021
SELL
$221.6 - $272.71 $185,700 - $228,530
-838 Reduced 7.82%
9,884 $2.28 Million
Q2 2021

Jul 30, 2021
SELL
$180.55 - $233.54 $46,401 - $60,019
-257 Reduced 2.34%
10,722 $2.46 Million
Q1 2021

Apr 27, 2021
SELL
$164.32 - $212.72 $140,986 - $182,513
-858 Reduced 7.25%
10,979 $2.05 Million
Q4 2020

Jan 21, 2021
SELL
$130.46 - $172.63 $90,539 - $119,805
-694 Reduced 5.54%
11,837 $2 Million
Q3 2020

Oct 16, 2020
SELL
$146.22 - $169.13 $280,742 - $324,729
-1,920 Reduced 13.29%
12,531 $1.86 Million
Q2 2020

Jul 22, 2020
SELL
$136.42 - $164.18 $42,972 - $51,716
-315 Reduced 2.13%
14,451 $2.37 Million
Q1 2020

May 05, 2020
BUY
$119.05 - $147.35 $1.53 Million - $1.89 Million
12,839 Added 666.27%
14,766 $2.05 Million
Q4 2019

Feb 05, 2020
BUY
$106.92 - $132.43 $206,034 - $255,192
1,927 New
1,927 $253,000
Q2 2019

Jul 29, 2019
SELL
$110.79 - $129.32 $941,604 - $1.1 Million
-8,499 Closed
0 $0
Q1 2019

Apr 18, 2019
BUY
$111.31 - $131.02 $946,023 - $1.11 Million
8,499 New
8,499 $1.1 Million
Q4 2018

Jan 16, 2019
SELL
$105.9 - $118.64 $1.39 Million - $1.56 Million
-13,138 Closed
0 $0
Q3 2018

Oct 17, 2018
BUY
$85.86 - $107.31 $15,969 - $19,959
186 Added 1.44%
13,138 $1.41 Million
Q2 2018

Jul 18, 2018
SELL
$75.7 - $86.88 $13,777 - $15,812
-182 Reduced 1.39%
12,952 $1.11 Million
Q1 2018

Apr 16, 2018
BUY
$74.21 - $87.6 $133,652 - $157,767
1,801 Added 15.89%
13,134 $1.02 Million
Q4 2017

Jan 26, 2018
BUY
$81.94 - $87.89 $104,309 - $111,883
1,273 Added 12.65%
11,333 $957,000
Q3 2017

Oct 10, 2017
BUY
$77.07 - $85.54 $775,324 - $860,532
10,060
10,060 $861,000

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Highland Capital Management, LLC Portfolio

Follow Highland Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email